Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yazmin P, Carrasco"'
Autor:
Niquo Ceberio, Peter Le, Jasmón Bailey, Sonthonax Vernard, Nichole Coleman, Yazmin P Carrasco, Telisa King, Kirsten Bibbins-Domingo, Tung Nguyen, Audrey Parangan-Smith, Kelechi Uwaezuoke, Robert C Rivers, Kenjus Watson, Leticia Márquez-Magaña, Kala M Mehta
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0294307 (2024)
ObjectiveThe unprecedented events of 2020 required a pivot in scientific training to better prepare the biomedical research workforce to address global pandemics, structural racism, and social inequities that devastate human health individually and e
Externí odkaz:
https://doaj.org/article/743a40c129144d818190c1e249d28220
Autor:
Robert A Hiatt, Yazmin P Carrasco, Alan L Paciorek, Lauren Kaplan, Marc B Cox, Carlos J Crespo, Andrew Feig, Karsten Hueffer, Harris McFerrin, Keith Norris, Elizabeth Roberts-Kirchhoff, Carrie L Saetermoe, Gillian Beth Silver, Katherine Snyder, Arturo R Zavala, Audrey G Parangan-Smith, Diversity Program Consortium
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274100 (2022)
BackgroundThe lack of race/ethnic and gender diversity in grants funded by the National Institutes of Health (NIH) is a persistent challenge related to career advancement and the quality and relevance of health research. We describe pilot programs at
Externí odkaz:
https://doaj.org/article/da39c65205594ab69a83253e3b4423dd
Autor:
Robert A, Hiatt, Yazmin P, Carrasco, Alan L, Paciorek, Lauren, Kaplan, Marc B, Cox, Carlos J, Crespo, Andrew, Feig, Karsten, Hueffer, Harris, McFerrin, Keith, Norris, Elizabeth, Roberts-Kirchhoff, Carrie L, Saetermoe, Gillian Beth, Silver, Katherine, Snyder, Arturo R, Zavala, Audrey G, Parangan-Smith
Publikováno v:
PloS one. 17(9)
Background The lack of race/ethnic and gender diversity in grants funded by the National Institutes of Health (NIH) is a persistent challenge related to career advancement and the quality and relevance of health research. We describe pilot programs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6cf29d30ec913c9fd8658138941d6c
https://pubmed.ncbi.nlm.nih.gov/36137156
https://pubmed.ncbi.nlm.nih.gov/36137156
Autor:
Robert Rivers, Kelechi Uwaezuoke, Peter Lê, Leticia Márquez-Magaña, Kala M. Mehta, Jasmón Bailey, Sonthonax Vernard, Niquo Ceberio, Tung T. Nguyen, Yazmin P. Carrasco, Kirsten Bibbins-Domingo, Kenjus Watson, Audrey Parangan-Smith
Publikováno v:
Nature Computational Science. 1:242-243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e604eec7954a67c33decc21f74cf1556
https://doi.org/10.1038/s43588-021-00063-6
https://doi.org/10.1038/s43588-021-00063-6
Publikováno v:
Journal of the American Chemical Society. 138:7130-7142
We describe the isolation, structure elucidation, and total synthesis of the novel marine natural product rifsaliniketal and the total synthesis of the structurally related variants salinisporamycin and saliniketals A and B. Rifsaliniketal was previo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54252b5b93f341f54e2ddef10ae6487e
https://doi.org/10.1021/jacs.6b03248
https://doi.org/10.1021/jacs.6b03248
Autor:
Qingxiang Sun, Yuh Min Chook, Hamid Mirzaei, Yazmin P. Carrasco, John B. MacMillan, Youcai Hu, Xiaofeng Guo
Publikováno v:
Proceedings of the National Academy of Sciences. 110:1303-1308
The polyketide natural product Leptomycin B inhibits nuclear export mediated by the karyopherin protein chromosomal region maintenance 1 (CRM1). Here, we present 1.8- to 2.0-Å-resolution crystal structures of CRM1 bound to Leptomycin B and related i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274372feadd617d6c7547e6e55aa1e80
https://doi.org/10.1073/pnas.1217203110
https://doi.org/10.1073/pnas.1217203110
Autor:
Keith H. Pannell, Armando Varela-Ramirez, Renato J. Aguilera, Margaret C Costanzo, Yazmin P. Carrasco
Publikováno v:
Cell Biology and Toxicology. 27:159-168
In this report, we have tested the cytotoxicity of two organotin (OT) compounds by flow cytometry on a panel of immortalized cancer cell lines of human and murine origin. Although the OT compounds exhibited varying levels of cytotoxicity, diphenylmet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96d1280cce7fc3541541a52f1e7c99dd
https://doi.org/10.1007/s10565-010-9178-y
https://doi.org/10.1007/s10565-010-9178-y
Autor:
Srawan K. Thodupunoori, Francisco Cervantes-Lee, Israel A. Alamudun, Keith H. Pannell, Yazmin P. Carrasco, Fabiola D. Gomez
Publikováno v:
Journal of Organometallic Chemistry. 691:1790-1796
The reaction between ClCH 2 –R–CH 2 Cl, R = p -C 6 H 4 , and [Ph 3 Sn] − Li + yields Ph 3 Sn–CH 2 –R–CH 2 –SnPh 3 ( 1 ) in high yield. The related known compound R = CH 2 CH 2 ( 1a ) is synthesized by the reaction of the di-Grignard rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7765d6c81cb0f5efc2acf493e99f49f4
https://doi.org/10.1016/j.jorganchem.2005.12.040
https://doi.org/10.1016/j.jorganchem.2005.12.040
Autor:
Trey Ideker, Malia B. Potts, Federico Cubillos, Michael A. White, Gamze B. Bulut, Yazmin P. Carrasco, Guanghua Xiao, Hyun Seok Kim, Yi Hung Ou, John B. MacMillan, Saurabh Mendiratta, Kurt W. Fisher, Robert E. Lewis, Youcai Hu, Yang Xie, Mireya L. Herrera-Herrera, Matan Hofree, Lily Jun Shen Huang
Publikováno v:
Science signaling, vol 6, iss 297
A challenge for biomedical research is the development of pharmaceuticals that appropriately target disease mechanisms. Natural products can be a rich source of bioactive chemicals for medicinal applications but can act through unknown mechanisms and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1dfc6b0cf74b781b500a0461a533a0a
https://pubmed.ncbi.nlm.nih.gov/24129700
https://pubmed.ncbi.nlm.nih.gov/24129700
Autor:
Yazmin P. Carrasco, Rebecca L. Maglathlin, Ana Ruiz-Saenz, Mark M. Moasser, Jack Taunton, Manbir Sandhu
Publikováno v:
Cancer Research. 75:2635-2635
There is increasing evidence implicating HER3 in several types of cancer, as a resilient copartner for HER2 in HER2-amplified cancers, and as a driver of resistance in many other types of cancer. However, the development of targeted therapies to inac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8999b0a857fe57d7208497e9f5bd58f2
https://doi.org/10.1158/1538-7445.am2015-2635
https://doi.org/10.1158/1538-7445.am2015-2635